PembrolizumabMyocarditis secondary to fatal polymyositis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1691卷 / 1期

关键词：

D O I：

10.1007/s40278-018-42469-9

中图分类号：

学科分类号：

摘要：

引用

下载

收藏

页码：214 / 214

相关论文

共 50 条

[31] PembrolizumabMyocarditis and interstitial nephritis: case report
Reactions Weekly, 2023, 1949 (1) : 357 - 357
[32] Ipilimumab/nivolumab/pembrolizumabMyocarditis: case report
Reactions Weekly, 2022, 1914 (1) : 266 - 266
[33] PembrolizumabMyocarditis and complete heart block: case report
Reactions Weekly, 2023, 1948 (1) : 360 - 360
[34] PembrolizumabMyocarditis, myositis and myasthenia gravis: case report
Reactions Weekly, 2023, 1969 (1) : 308 - 308
[35] PembrolizumabMyocarditis and guillain barre syndrome: case report
Reactions Weekly, 2022, 1917 (1) : 478 - 478
[36] PembrolizumabMyocarditis, atrial fibrillation and pneumonitis: case report
Reactions Weekly, 2023, 1949 (1) : 358 - 358
[37] PembrolizumabMyocarditis and complete heart block: case report
Reactions Weekly, 2022, 1901 (1) : 395 - 395
[38] Polymyositis: A Case Report
Rios-Gomez, Mariana
Villanueva-Salinas, Arturo
Arias-Martinez, Sarahi
Pimentel-Esparza, Juan Andres
Aguirre-Sanchez, Alejandra
Delgado-Villafana, Javier
Perez-Santana, Martha Elia
Montes-Ramirez, Juan E.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (08)
[39] PembrolizumabMyocarditis and acute inflammatory demyelinating polyradiculoneuropathy: case report
Reactions Weekly, 2022, 1922 (1) : 486 - 486
[40] Lenvatinib/pembrolizumabMyocarditis and grade 1 hyperthyroidism: case report
Reactions Weekly, 2022, 1918 (1) : 289 - 289

← 1 2 3 4 5 →